KLF5 and breast cancer: The deubiquitinase (DUB) BAP1 had been reported to regulate KLF5 stability in breast cancer cells (19, 25), so we hypothesize that LINC00152 mediates KLF5 depending on the binding of BAP1 and KLF5.